Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.

The FDA signed off on 55 new drugs in 2024, down from 60-plus in 2023.

2025年1月2日 · But, while the number of drugs becoming more costly is going up, the median scale of drug price increases has fallen significantly over the past decade, from 9% in 2015 to 4.5% in 2024, Reuters ...

There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...

Every year, we tap Evaluate's annual preview report to assess the biggest potential new drugs of the year ahead. Typically, major pharmaceutical and biotechnology companies are featured, each ...

2024年12月17日 · As for the FDA's rejection of Andexxa, the company said in an email that it will keep the treatment on the market in the U.S. AZ confirmed the CRL, which was reported last week by Pink Sheet.. In ...

2024年12月12日 · In July, Lonza noted that CHI sales were down about 6% during the first six months of 2024. The CDMO attributed the downturn to “continued destocking in the pharma capsules business.” In ...

2024年11月6日 · On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed to win the U.S. | Over his first term, Donald Trump advocated for ...

2024年12月11日 · Gilead Sciences’ top money maker Biktarvy has been the company’s crown jewel for years now, but with the HIV med inching toward a 2033 patent cliff, the drugmaker at its HIV investor event ...

2025年1月2日 · After a compounding group sued the FDA over its decision to declare the shortage of tirzepatide over, Eli Lilly is looking to muscle in on the case.